
Helaina launches precision fermented human lactoferrin equivalent
Helaina has launched an ingredient called effera, which it claims is the first human lactoferrin equivalent manufactured using precision fermentation.
Helaina (New York) has launched an ingredient called effera, which it claims is the first human lactoferrin equivalent manufactured using precision fermentation. Effera is fermented from the yeast strain Komagataella phaffii, and replicates an equivalent protein to lactoferrin found in human colostrum and maternal milk. New pre-clinical and clinical data demonstrates the ingredient’s bioavailability, safety, and similar profile human lactoferrin, states the company in an announcement.
A
“We are starting to see with real clinical evidence and science-backed research that human proteins can outperform bovine milk protein, opening a new world where our nutrients can do more for us,” said Laura Katz, founder and CEO of Helaina, in a press release. “This exciting new discovery fosters our goal of developing a portfolio of advanced human bioactive proteins that address real health needs and new possibilities in nutrition science.”
Watch our recent
Reference
Kim, B.J.; Kuhfield, R.F.; Haas, J.L.; Anaya, Y.M.; Martinez, R.R.; Sah, B.N.P.; Breen, B.; Newsham, K.; Malinczak, C.A.; Dallas, D.C. Digestive Profiles of Human Milk, Recombinant Human and Bovine Lactoferrin: Comparing the Retained Intact Protein and Peptide Release. Nutrients. 2024, 16 (14), 2360. DOI: 10.3390/nu16142360
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.





